Jair Isai Ortega-Gaxiola

Jair Isai Ortega-Gaxiola

Auto-generated profile, based on publicly available information

Jair Isai Ortega-Gaxiola


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2025 in Inorganics
Verified
Journal Article
Open access
PDF file
JOJair Isai Ortega-Gaxiola
Jair Isai Ortega-Gaxiola
Juan Sebastián Serrano-GarcíaJuan Sebastián Serrano-García
Juan Sebastián Serrano-García
AFAndrés Amaya Florez
Andrés Amaya Florez
JRJordi R.-Galindo
Jordi R.-Galindo
AAAntonino Arenaza-Corona
Antonino Arenaza-Corona
DAVID MORALES-MORALESDAVID MORALES-MORALES
DAVID MORALES-MORALES
Iminophosphine ligands find extensive applications in homogeneous catalysis; however, their potential antitumor activity is currently being explored. Including biologically active moieties, such as aminoalcohols, could enhance this activity further. Therefore, we have synthesised a novel series of Pd(II) and Pt(II) iminophosphine complexes incorporating aminoalcohols as biologically active moieties to explore the potential of enhancing this activity. The series of Pd(II) complexes includes complexes 2a, 2f, and 2h, which were previously reported by our research group as catalysts in Suzuki–Miyaura cross-coupling reaction in aqueous media. Besides their complete characterisation, some structures have been unequivocally corroborated by single-crystal X-ray diffraction (SC-XRD). To evaluate the cytotoxic potential of the complexes, a preliminary in vitro study was conducted on different cancerous cell lines, including using COS-7 cells as a healthy cell line. Notably, complexes 2e, 2f, and 3b exhibited selectivity towards human chronic myelogenous leukaemia (K562), demonstrating IC50 values of 7.73 ± 1.4 µM, 8.53 ± 1.9 µM, and 8.83 ± 1.5 µM, respectively. Remarkably, the selectivity of these complexes surpassed that of cisplatin. Furthermore, in silico analysis indicated a higher binding energy of these complexes to DNA when compared to cisplatin.